$NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NAVIDEA BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NAVIDEA BIOPHARMACEUTICALS, INC. for free.

CIK Number: 0000810509
IRS Number: 311080091
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NAVB
Company Address: 4995 BRADENTON AVENUE SUITE 240 DUBLIN 43017
Phone number: 6147937500
Former name: NEOPROBE CORP, date of change: 1994-07-14

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Market Capitalization: $77.59M
Prev close: $0.52
Average Daily Volume: 833,077
Days Low: $0.49
Year Low: $0.26
Year High: $1.51

NAVIDEA BIOPHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 19 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGiftG0.0028,000050,00078 K to 50 K (-35.90 %)
Jul 03 2017NAVBNAVIDEA BIOPHARMAC ...Regan William J.SVP & CCOBuyP0.5320,00010,586172,977153 K to 173 K (+13.07 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorGrantA0.0050,00050291,446241.4 K to 291.4 K (+20.71 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGrantA0.0050,0005078,00028 K to 78 K (+178.57 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Greene Mark IDirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Greene Mark IDirectorGrantA0.0050,00050107,24457.2 K to 107.2 K (+87.35 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Fiorino Anthony S.DirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Fiorino Anthony S.DirectorGrantA0.0050,0005078,00028 K to 78 K (+178.57 %)
May 31 2017NAVBNAVIDEA BIOPHARMAC ...Latkin JedCOO and CFOBuyP0.447,6003,31750,15942.6 K to 50.2 K (+17.86 %)
May 23 2017NAVBNAVIDEA BIOPHARMAC ...Latkin JedCOO and CFOBuyP0.4511,2005,03942,55931.4 K to 42.6 K (+35.72 %)
May 23 2017NAVBNAVIDEA BIOPHARMAC ...Latkin JedCOO and CFOBuyP0.4514,1596,38731,35917.2 K to 31.4 K (+82.32 %)
May 16 2017NAVBNAVIDEA BIOPHARMAC ...GOLDBERG MICHAEL MPresident & CEOGrantA0.46106,02148,7595,921,0235.8 M to 5.9 M (+1.82 %)
May 05 2017NAVBNAVIDEA BIOPHARMAC ...Latkin JedCOO and CFOOption ExerciseA0.001,000,00001,065,000

View all NAVIDEA BIOPHARMACEUTICALS, INC. insider transactions.